The US Oncology Network selects Myriad Genetics as preferred provider for Hereditary Cancer Testing

by Myriad Genetics Iberia

Myriad Genetics, Inc. (NASDAQ:MYGN) and The US Oncology Network (The Network) announced today that The Network has selected Myriad Genetic Laboratories as its preferred provider laboratory for heredit...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A dietary supplement has beneficial effe...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...

Photos Stream